Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Yong-Chen Lu

Concepts (250)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
13
2022
148
4.180
Why?
Receptors, Antigen, T-Cell
10
2022
48
3.070
Why?
Lymphocytes, Tumor-Infiltrating
17
2022
76
2.990
Why?
Immunotherapy
6
2024
235
2.500
Why?
T-Lymphocytes
9
2022
325
2.480
Why?
Immunotherapy, Adoptive
8
2019
163
2.480
Why?
Neoplasms
10
2024
1251
2.420
Why?
CD4-Positive T-Lymphocytes
5
2024
158
1.620
Why?
Cancer Vaccines
4
2021
80
1.400
Why?
High-Throughput Nucleotide Sequencing
3
2021
169
1.240
Why?
Mutation
13
2019
1280
0.960
Why?
Single-Cell Analysis
3
2022
63
0.760
Why?
CD8-Positive T-Lymphocytes
8
2024
125
0.700
Why?
Immune System
1
2020
43
0.680
Why?
Alcohol Oxidoreductases
1
2019
13
0.650
Why?
HLA-DP beta-Chains
2
2017
2
0.610
Why?
Neoplasm Proteins
2
2017
320
0.590
Why?
Urinary Bladder Neoplasms
1
2019
158
0.570
Why?
Genetic Therapy
2
2017
120
0.560
Why?
DNA-Binding Proteins
2
2019
418
0.540
Why?
Melanoma
3
2016
280
0.520
Why?
Humans
39
2025
50503
0.510
Why?
Animals
16
2024
13124
0.490
Why?
Immunodominant Epitopes
2
2015
8
0.460
Why?
Proto-Oncogene Proteins p21(ras)
4
2019
67
0.460
Why?
Signal Transduction
7
2024
1624
0.460
Why?
Protein Phosphatase 1
1
2013
7
0.430
Why?
Cytokines
4
2019
606
0.430
Why?
Phosphoprotein Phosphatases
1
2013
17
0.430
Why?
Osteoarthritis
2
2024
61
0.420
Why?
Lymphocyte Activation
5
2021
164
0.420
Why?
Proto-Oncogene Proteins c-rel
2
2010
5
0.410
Why?
Antibodies, Monoclonal
1
2016
462
0.390
Why?
Colorectal Neoplasms
3
2019
260
0.360
Why?
Neoplasm Metastasis
3
2022
232
0.350
Why?
CCAAT-Enhancer-Binding Protein-beta
1
2009
4
0.330
Why?
Toll-Like Receptors
1
2009
27
0.320
Why?
Transcriptome
2
2022
313
0.320
Why?
CCAAT-Enhancer-Binding Protein-delta
1
2009
22
0.320
Why?
Lipopolysaccharides
2
2022
197
0.310
Why?
Glioblastoma
2
2021
94
0.310
Why?
Toll-Like Receptor 4
1
2008
52
0.290
Why?
Adoptive Transfer
3
2018
30
0.260
Why?
Cells, Cultured
5
2021
1571
0.250
Why?
Bone Density
2
2025
386
0.250
Why?
Gene Expression Profiling
2
2021
1025
0.250
Why?
Sarcoma, Synovial
1
2025
4
0.240
Why?
Autoantigens
2
2015
48
0.240
Why?
Hip Fractures
1
2025
47
0.240
Why?
Middle Aged
11
2025
12611
0.230
Why?
Bioprinting
1
2024
1
0.230
Why?
Nanofibers
1
2024
7
0.230
Why?
Skin, Artificial
1
2024
10
0.230
Why?
Nutrition Assessment
1
2024
64
0.230
Why?
Phantoms, Imaging
1
2025
122
0.230
Why?
Humerus
1
2024
18
0.230
Why?
T-Lymphocytes, Regulatory
2
2016
82
0.220
Why?
Geriatric Assessment
1
2024
116
0.220
Why?
Gene Library
2
2014
41
0.220
Why?
Nutritional Status
1
2024
136
0.220
Why?
Sarcopenia
1
2024
95
0.220
Why?
Lumbar Vertebrae
1
2024
102
0.220
Why?
Receptors, Estrogen
1
2024
132
0.210
Why?
Osteoporosis
1
2025
156
0.210
Why?
beta Catenin
1
2024
97
0.210
Why?
Adipocytes
1
2024
126
0.210
Why?
Artificial Intelligence
1
2024
96
0.210
Why?
Leptin
1
2024
143
0.210
Why?
Aged
6
2025
9741
0.200
Why?
Tumor Suppressor Protein p53
3
2022
213
0.200
Why?
Tomography, X-Ray Computed
2
2025
1164
0.200
Why?
Thyroid Neoplasms
1
2024
112
0.200
Why?
Nephritis
1
2022
23
0.200
Why?
Clone Cells
2
2019
70
0.200
Why?
Receptors, Immunologic
1
2022
35
0.200
Why?
Bone Marrow
1
2024
363
0.200
Why?
Alleles
2
2014
256
0.190
Why?
Bone Neoplasms
1
2024
179
0.190
Why?
Female
16
2025
27081
0.190
Why?
Ureteral Obstruction
1
2022
61
0.190
Why?
HLA-A Antigens
2
2019
10
0.190
Why?
Osteogenesis
1
2024
356
0.190
Why?
Human papillomavirus 16
1
2021
44
0.190
Why?
Adaptor Proteins, Signal Transducing
2
2014
198
0.180
Why?
Male
10
2025
25907
0.180
Why?
T-Cell Antigen Receptor Specificity
2
2017
4
0.180
Why?
Membrane Glycoproteins
1
2022
245
0.180
Why?
Papillomavirus Vaccines
1
2021
67
0.170
Why?
Interleukin-2
2
2017
71
0.170
Why?
Smad5 Protein
1
2019
1
0.160
Why?
Mucin-4
1
2019
1
0.160
Why?
Renal Insufficiency, Chronic
1
2022
174
0.160
Why?
Uterine Cervical Neoplasms
1
2021
276
0.150
Why?
NF-kappa B
3
2024
315
0.150
Why?
Cell Differentiation
1
2021
640
0.150
Why?
Mice
7
2024
5687
0.150
Why?
Diabetes Mellitus, Type 2
1
2023
519
0.140
Why?
Adult
8
2024
13577
0.140
Why?
Epitopes, T-Lymphocyte
2
2014
25
0.140
Why?
Hematopoietic Stem Cell Transplantation
1
2022
578
0.140
Why?
Administration, Intravenous
1
2017
70
0.140
Why?
Colonic Neoplasms
1
2019
158
0.140
Why?
Membrane Proteins
1
2019
332
0.140
Why?
Flow Cytometry
3
2016
474
0.140
Why?
Exome
2
2014
48
0.130
Why?
CTLA-4 Antigen
1
2016
23
0.130
Why?
Cell Line, Tumor
2
2017
1398
0.130
Why?
Gene Expression Regulation
2
2019
955
0.130
Why?
T-Lymphocytes, Helper-Inducer
1
2016
39
0.130
Why?
Programmed Cell Death 1 Receptor
1
2016
39
0.130
Why?
Lung Neoplasms
2
2025
601
0.130
Why?
Transcription Factors
1
2019
565
0.130
Why?
Protein Binding
2
2014
654
0.130
Why?
Transplantation, Autologous
1
2017
481
0.120
Why?
Gastrointestinal Neoplasms
1
2015
40
0.120
Why?
Treatment Outcome
4
2021
5283
0.120
Why?
Neutrophils
2
2014
145
0.120
Why?
Time Factors
2
2021
2935
0.120
Why?
Respiratory Burst
1
2014
4
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2019
833
0.120
Why?
Hepatitis B e Antigens
1
2014
4
0.120
Why?
Histocompatibility Antigens
1
2014
5
0.120
Why?
Chemotaxis, Leukocyte
1
2014
13
0.120
Why?
Epitope Mapping
1
2014
6
0.120
Why?
Bile Ducts, Intrahepatic
1
2014
13
0.110
Why?
Bile Duct Neoplasms
1
2014
27
0.110
Why?
Cholangiocarcinoma
1
2014
25
0.110
Why?
Th1 Cells
1
2014
53
0.110
Why?
Monocytes
1
2014
127
0.110
Why?
Peptides
1
2014
221
0.110
Why?
Amino Acid Sequence
1
2014
574
0.100
Why?
Gene Knockdown Techniques
1
2013
105
0.100
Why?
Genes, T-Cell Receptor
2
2022
5
0.100
Why?
Base Sequence
1
2013
639
0.100
Why?
TNF Receptor-Associated Factor 2
1
2011
4
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
572
0.100
Why?
Molecular Sequence Data
1
2013
778
0.100
Why?
Autoimmunity
1
2011
34
0.100
Why?
Risk Factors
3
2025
3724
0.090
Why?
Cell Line
1
2014
988
0.090
Why?
Forkhead Transcription Factors
1
2012
110
0.090
Why?
Disease Progression
1
2014
829
0.090
Why?
Severe Combined Immunodeficiency
1
2010
12
0.090
Why?
Clinical Trials as Topic
1
2013
486
0.090
Why?
Gene Rearrangement
1
2010
65
0.090
Why?
Clonal Anergy
1
2010
13
0.090
Why?
Mice, Knockout
3
2024
844
0.080
Why?
Protein Kinase C
1
2010
71
0.080
Why?
Dendritic Cells
2
2022
135
0.080
Why?
Remission Induction
2
2021
208
0.080
Why?
Isoenzymes
1
2010
168
0.080
Why?
Interleukin-1 Receptor-Associated Kinases
1
2009
11
0.080
Why?
Myeloid Differentiation Factor 88
1
2009
32
0.080
Why?
Chromosome Aberrations
1
2010
280
0.080
Why?
Antineoplastic Agents
1
2017
1172
0.080
Why?
Nuclear Proteins
1
2010
238
0.080
Why?
Breast Neoplasms
1
2018
1201
0.080
Why?
Transcriptional Activation
1
2009
119
0.080
Why?
Inflammation Mediators
1
2009
111
0.080
Why?
Antigen Presentation
2
2019
25
0.070
Why?
Cell Separation
2
2019
92
0.070
Why?
Complement C3a
1
2007
3
0.070
Why?
Complement C5a
1
2007
4
0.070
Why?
Macrophages
1
2009
364
0.070
Why?
Fibroblasts
2
2024
336
0.060
Why?
Obesity
2
2024
1121
0.060
Why?
Tuberculosis, Spinal
1
2025
5
0.060
Why?
Automation
1
2025
18
0.060
Why?
Calibration
1
2025
57
0.060
Why?
Lymphocyte Count
2
2016
19
0.060
Why?
Spinal Neoplasms
1
2025
30
0.060
Why?
Diagnostic Errors
1
2025
66
0.060
Why?
Gelatin
1
2024
23
0.060
Why?
Absorptiometry, Photon
1
2025
155
0.060
Why?
ROC Curve
1
2025
226
0.060
Why?
Hydrogels
1
2024
17
0.060
Why?
Hyaluronic Acid
1
2024
34
0.060
Why?
Nutrition Surveys
1
2024
113
0.060
Why?
Keratinocytes
1
2024
77
0.060
Why?
Iodine Radioisotopes
1
2024
35
0.060
Why?
Tissue Scaffolds
1
2024
36
0.060
Why?
Hedgehog Proteins
1
2024
32
0.060
Why?
Estrogen Receptor alpha
1
2024
88
0.050
Why?
Tissue Engineering
1
2024
66
0.050
Why?
Mice, Inbred C57BL
2
2024
1808
0.050
Why?
Bone Morphogenetic Proteins
1
2024
57
0.050
Why?
Bone Marrow Cells
1
2024
196
0.050
Why?
Wnt Signaling Pathway
1
2024
86
0.050
Why?
Transforming Growth Factor beta
1
2024
136
0.050
Why?
Swine
1
2024
408
0.050
Why?
Lipid Metabolism
1
2023
175
0.050
Why?
Th17 Cells
1
2022
25
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Neoplasm Grading
1
2021
122
0.050
Why?
Prevalence
1
2024
971
0.050
Why?
Incidence
1
2024
1032
0.050
Why?
Diagnosis, Differential
1
2025
1033
0.050
Why?
Gene Regulatory Networks
1
2022
106
0.050
Why?
Pain
1
2024
387
0.050
Why?
Arginine
1
2022
187
0.040
Why?
Nitric Oxide
1
2022
259
0.040
Why?
Host-Pathogen Interactions
1
2021
135
0.040
Why?
Risk Assessment
1
2024
1270
0.040
Why?
Blotting, Western
2
2011
578
0.040
Why?
Cross-Sectional Studies
1
2024
1610
0.040
Why?
Transduction, Genetic
1
2019
46
0.040
Why?
Immunologic Memory
1
2019
29
0.040
Why?
Lung
2
2016
504
0.040
Why?
Coculture Techniques
1
2019
142
0.040
Why?
Transplantation Conditioning
1
2019
87
0.040
Why?
Phenotype
2
2012
739
0.040
Why?
Neoplastic Cells, Circulating
1
2019
74
0.040
Why?
Lymphatic Metastasis
1
2019
222
0.040
Why?
Molecular Targeted Therapy
1
2019
123
0.040
Why?
Cell Proliferation
1
2021
985
0.040
Why?
Proteasome Endopeptidase Complex
1
2018
116
0.040
Why?
Aged, 80 and over
1
2025
3226
0.040
Why?
HLA-DRB1 Chains
1
2017
5
0.040
Why?
Antigen-Presenting Cells
1
2017
23
0.040
Why?
Pilot Projects
1
2019
698
0.030
Why?
Cross Reactions
1
2016
39
0.030
Why?
HLA-C Antigens
1
2015
4
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Inflammation
2
2011
610
0.030
Why?
Young Adult
1
2025
4102
0.030
Why?
Proto-Oncogene Proteins
1
2015
145
0.030
Why?
Clinical Trials, Phase II as Topic
1
2014
45
0.030
Why?
Chemokines
1
2014
75
0.030
Why?
Vaccination
1
2016
280
0.030
Why?
Receptor, erbB-2
1
2014
75
0.030
Why?
United States
1
2024
4955
0.030
Why?
B-Lymphocytes
1
2014
171
0.030
Why?
Recombinant Proteins
1
2014
476
0.030
Why?
Dose-Response Relationship, Immunologic
1
2012
13
0.030
Why?
Whole-Body Irradiation
1
2012
132
0.020
Why?
Spectral Karyotyping
1
2010
6
0.020
Why?
Endonucleases
1
2010
15
0.020
Why?
Polymerase Chain Reaction
1
2011
449
0.020
Why?
Lymphoma
1
2010
67
0.020
Why?
Survival Analysis
1
2010
661
0.020
Why?
DNA Damage
1
2010
301
0.020
Why?
Apoptosis
1
2014
1097
0.020
Why?
Mice, Transgenic
1
2010
540
0.020
Why?
Receptor, Anaphylatoxin C5a
1
2007
3
0.020
Why?
Receptors, Chemokine
1
2007
13
0.020
Why?
Complement Activation
1
2007
24
0.020
Why?
Cattle
1
2007
205
0.020
Why?
Actins
1
2007
114
0.020
Why?
Disease Models, Animal
1
2010
1436
0.020
Why?
Hematopoietic Stem Cells
1
2007
197
0.020
Why?
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description